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of our manuscript demonstrating significant changes in CLL cells transduced with STAT3 shRNA, but not with the empty retrovirus, such as down-regulation of the expression of STAT3 gene, STAT3-regulated genes, and STAT3 protein levels. Obviously, these changes could not be obtained with washable GFP-positive sticky proteins. Nevertheless, Lévy et al should be congratulated on generating an improved transduction system. 
To the editor:
Tissue factor mutated at the allosteric Cys 186 -Cys 209 disulfide bond is severely impaired in decrypted procoagulant activity
Tissue factor (TF) is the cellular trigger of extrinsic coagulation and a signaling coreceptor for protease-activated receptor 2 (PAR2). A recent paper in Blood 5 reproduced these key findings but concluded that the allosteric disulfide is not essential for TF's procoagulant activity, taking into consideration only data at supraphysiologic concentrations of TF ligands while ignoring the mutant's severe defect in clotting assays, the "gold standard" for TF procoagulant activity. Experiments performed solely at 1000-fold the plasma concentration (100pM) of FVIIa indicated that disulfide mutated TF undergoes normal conversion from inactive to active TF, termed decryption, induced by cell lysis or other stimuli. The following experiments at physiologically relevant concentrations of FVII/VIIa raise concerns about the general validity of this conclusion.
Wild-type TF or TF C209A were expressed to increasing levels by adenoviral cotransduction with PAR2. 2 TF procoagulant activity was measured with 10 to 20nM FVIIa, concentrations sufficient for equivalent TF-FVIIa binary complex signaling activity of wildtype or TF C209A . 2 Extreme overexpression of TF C209A (300 ppc) yielded cell-surface TF procoagulant activity that was similar to cells transduced with 10 ppc of wild-type TF adenovirus ( Figure  1A ). Kothari's study 5 predicted a comparable increase in activity of wild-type TF and TF C209A , but decryption induced by cell lysis was much more efficient in cells expressing very low levels of wild-type TF. Kothari 5 did not observe comparable overexpression of TF C209A , which may be explained by our cotransduction with PAR2. Therefore, cells were transduced with high-dose TF C209A or low-dose wild-type TF virus in the presence of PAR2 or control Ad5 virus ( Figure 1B) . With both protocols, expression of the mutant was high and the decrypted activity of wild-type TF far exceeded that of TF C209A . Thus, even with extreme overexpression, TF C209A did not achieve decrypted activity comparable with wild-type TF.
These experiments are inconsistent with the broad conclusion that disulfide mutated TF has the same specific procoagulant activity and is decrypted in the same manner as wild-type TF. The functional impairment of disulfide mutated TF and the demonstrated role of protein disulfide isomerase in thrombus formation in vivo 6,7 warrant further investigations into thiol/ disulfide exchange and S-nitrosylation pathways 2,8-10 as regulators of TF prothrombotic activity. . TF cell-surface proteolytic activity was quantified by measuring the rate of FXa generation after addition of 10nM FVIIa and 100nM FX. Subsequently, cells were lysed in 15mM octylglucoside and, after dilution to 5mM octylglucosides, the rate of FXa generation was measured upon addition of 20nM FVIIa and 100nM FX. For Western blotting, cells were directly lysed in nonreducing sample buffer and transfers were probed with polyclonal antibody to human TF. (B) Cells were transduced with the indicated TF virus doses in the presence of 200 ppc empty Ad5 control or PAR2 virus, followed by FXa generation assay with 10nM FVIIa and 100nM FX in octylglucoside lysates, as described above. Transfers were probed with polyclonal antibody to human TF or, as a loading control, to integrin ␤1.
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